Esterified vitamin E — more stable than free tocopherol; hydrolyzed to active form during absorption. Standard supplement form. Topical formulations questionable for skin benefit; vaping-related EVALI lung injury association.
Half-Life & Elimination Curve (PO: 48h)
Plasma (PO)t½ Decay (48h)
0×t½0h100%
1×t½48h50%
2×t½4d25%
3×t½6d12.5%
4×t½8d6.3%
5×t½10d3.1%
Elimination t½48h (PO)
Rate Constant (ke)0.0144 h⁻¹
Time to Peak (Tmax)12.1h
Clearance (CL)0.505 L/h
97% Washout (5×t½)10d
Dosing Guidelines
Oral (PO): Typical 400 IU (Range: 22–1000 IU)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 50% · Volume of Distribution (Vd): 35 L · Absorption (ka): 0.25 h⁻¹ (t½ka ≈ 2.77h) [PMID 15623833]